FNArena’s Monitor keeps track of corporate earnings result releases, including broker views, ratings and target price changes and beat/miss assessments
The seasons have changed for Nufarm, for the better, generating a welcome return to a profitable outlook
Orica has always indicated the first half would be weak, but the extent of the latest downgrade has rattled the market
Michael Gable of Fairmont Equities notes consolidation following a solid run for Baby Bunting suggests a pull back is possible
FNArena’s Monitor keeps track of corporate earnings result releases, including broker views, ratings and target price changes and beat/miss assessments
As demand for home-based goods continues apace Harvey Norman is in a purple patch. How long will such buoyant times prevail?
Afterpay’s rapid global expansion has taken the market by storm but not all are convinced of its value
FNArena’s Monitor keeps track of corporate earnings result releases, including broker views, ratings and target price changes and beat/miss assessments
Could competition be stalking Appen as a result of an increasing number of smaller projects on offer? Several brokers suspect this may be the case
FNArena’s Monitor keeps track of corporate earnings result releases, including broker views, ratings and target price changes and beat/miss assessments
